S977 Comparative Efficacy and Safety of Tegoprazan vs Proton Pump Inhibitors for Erosive Esophagitis: A Meta-Analysis of Randomized Controlled Trials
Abstract
Introduction: Proton pump inhibitors (PPIs) remain the standard treatment option for erosive esophagitis (EE) but have notable limitations due to side effects associated with long-term use. Tegoprazan, a potassium-competitive acid suppressant (PCAB), may provide an alternative treatment option. In this study, we aim to evaluate the healing rates of erosive esophagitis using tegoprazan versus PPIs, along with their safety profiles. Methods: A comprehensive literature search was conducted in PubMed, Embase, and ClinicalTrials.gov through March 2025. Risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Pooled estimates were calculated using random-effects models in Review Manager 5.4. Results: Four randomized controlled trials encompassing a total of 812 patients were included in the analysis. Tegoprazan demonstrated similar healing rates to PPIs at both 4 weeks (relative risk [RR] 1.05; 95% confidence interval [CI] 0.99-1.11; P = 0.12) and 8 weeks (RR 1.02; 95% CI 0.98-1.06; P = 0.35). Subgroup analyses by dose (50 mg and 100 mg) showed no significant differences. While tegoprazan was associated with a slightly higher incidence of overall adverse events (61.8% vs 51.9%; RR 1.18; 95% confidence interval 0.99-1.40; P = 0.07), it had a lower incidence of headache (1.3% vs 4.2%; RR 0.40; 95% CI 0.08-2.00). Conclusion: Tegoprazan is non-inferior to PPIs in treating EE, demonstrating comparable efficacy and tolerability. It may serve as an effective alternative for…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 812 participants or records.
Read the paper
Related studies
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.